These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9311175)

  • 1. Hypersensitivity reactions to cisplatin following multiple uncomplicated courses: a report on two cases.
    Onoyama Y; Umezu T; Kuriaki Y; Honda N
    J Obstet Gynaecol Res; 1997 Aug; 23(4):347-52. PubMed ID: 9311175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy.
    Koren C; Yerushalmi R; Katz A; Malik H; Sulkes A; Fenig E
    Am J Clin Oncol; 2002 Dec; 25(6):625-6. PubMed ID: 12478013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.
    Ottaiano A; Tambaro R; Greggi S; Prato R; Di Maio M; Esposito G; Scala F; Barletta E; Losito S; De Vivo R; Iaffaioli VR; Pignata S
    Anticancer Res; 2003; 23(4):3465-8. PubMed ID: 12926091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
    Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation.
    Jones R; Ryan M; Friedlander M
    Gynecol Oncol; 2003 Apr; 89(1):112-5. PubMed ID: 12694663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions associated with platinum-containing antineoplastic agents for thoracic malignancies.
    Tamiya M; Kuhara H; Hirashima T; Kondo Y; Santo M; Morishita N; Suzuki H; Sasada S; Okamoto N; Kobayashi M; Kawase I
    Anticancer Res; 2011 Dec; 31(12):4525-8. PubMed ID: 22199326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin.
    Shukunami K; Kurokawa T; Kubo M; Kaneshima M; Kamitani N; Kotsuji F
    Tumori; 1999; 85(4):297-8. PubMed ID: 10587037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases.
    Libra M; Sorio R; Buonadonna A; Berretta M; Stefanovski P; Toffoli G; Mazzaglia G; Cordani N; Stivala F; Boiocchi M
    Tumori; 2003; 89(3):311-3. PubMed ID: 12908789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
    Markman M; Hsieh F; Zanotti K; Webster K; Peterson G; Kulp B; Spicel A; Belinson J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):25-8. PubMed ID: 14564516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.
    Taylor SE; Beck TL; Krivak TC; Zorn KK; Kelley JL; Edwards RP
    Gynecol Oncol; 2014 Jul; 134(1):68-72. PubMed ID: 24769036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: the first report of a case.
    Shukunami K; Kurokawa T; Kawakami Y; Kubo M; Kotsuji F
    Gynecol Oncol; 1999 Mar; 72(3):431-2. PubMed ID: 10053120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report.
    Greene DP; Ferriss JS; Jazaeri AA
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):265-7. PubMed ID: 19844714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paclitaxel hypersensitivity reactions in patients with advanced ovarian carcinoma].
    Kobierski J; Majdak E; Mielcarek P; Emerich J
    Ginekol Pol; 2002 Nov; 73(11):1015-20. PubMed ID: 12722392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience.
    Polyzos A; Tsavaris N; Kosmas C; Arnaouti T; Kalahanis N; Tsigris C; Giannopoulos A; Karatzas G; Giannikos L; Sfikakis PP
    Oncology; 2001; 61(2):129-33. PubMed ID: 11528251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
    Enrique E; Malek T; Castelló JV; de Mateo JA
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Regine WF; Valentino J; Arnold SM; Haydon RC; Sloan D; Kenady D; Strottmann J; Pulmano C; Mohiuddin M
    J Clin Oncol; 2001 Jul; 19(14):3333-9. PubMed ID: 11454880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
    Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
    Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer.
    Kanamori Y; Kigawa J; Minagawa Y; Irie T; Itamochi H; Cheng X; Okada M; Terakawa N
    Gynecol Obstet Invest; 1997; 44(1):57-60. PubMed ID: 9251956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.